Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Mdb Capital Holdings LLC (MDBH) Stock Forecast & Price Prediction United States | NASDAQ | Financial Services | Capital Markets
$3.85
-0.05 (-1.28%)Did MDBH Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if MDB Capital is one of their latest high-conviction picks.
MDBH has shown a year-to-date change of 18.8% and a 1-year change of -10.5%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for MDBH. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for MDBH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
The following stocks are similar to MDB Capital based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Mdb Capital Holdings LLC has a market capitalization of $39.66M with a P/E ratio of 2.0x. The company generates $4.91M in trailing twelve-month revenue with a -249.6% profit margin.
Revenue growth is +341.8% quarter-over-quarter, while maintaining an operating margin of -14.1% and return on equity of -32.6%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Investment firm focused on emerging technologies.
The company identifies and invests in breakthrough innovations in sectors like biotechnology and life sciences. It provides financial support and expertise to early-stage companies, aiming to accelerate their commercialization and growth.
Mdb Capital Holdings LLC plays a key role in connecting scientific innovations with market implementation, significantly impacting industries such as healthcare and nanotechnology.
Financial Services
Capital Markets
14
Mr. Christopher A. Marlett
United States
2023
MDB Capital Holdings, LLC reported its Q4 2025 earnings. For detailed insights, refer to the official earnings call transcript for financial performance and forecasts.
MDB Capital Holdings' Q4 2025 earnings reveal financial performance and strategic direction, impacting stock valuation and investor sentiment in the capital markets.
PatentVest's latest report highlights 40 programs and $19 billion in deals focused on obesity medicine, emphasizing significant industry investment and innovation.
The report highlights significant investment and innovation in obesity medicine, indicating potential growth opportunities in biotech and pharmaceuticals, impacting stock valuations in these sectors.
PatentVest has expanded its IP Legal Insights section, providing expert legal perspectives on intellectual property strategy and emerging technologies, enhancing resources for investors in innovation-driven sectors.
PatentVest's new IP Legal Insights section signals enhanced focus on intellectual property trends, which could influence investment strategies in tech and innovation sectors.
MDB Capital Holdings (NASDAQ: MDBH) will host a Zoom webinar on March 31, 2026, at 4:30 p.m. ET to discuss its Q4 and full-year 2025 results, with a press release to follow.
MDB Capital's upcoming webinar on Q4 and full-year 2025 results signals potential insights into performance and future growth, influencing investor sentiment and stock valuation.
PatentVest has completed a strategic intellectual property engagement with Porosome Therapeutics, which is developing a novel therapeutic platform for cellular secretion restoration.
The partnership indicates potential innovation in biotechnology, which could drive future revenue growth for both companies, attracting investor interest and impacting stock performance.
An analysis of over 1,200 patent documents identifies programs that are establishing strong market exclusivity versus those with uncertain longevity.
Patent analysis can signal which companies hold competitive advantages and potential revenue streams, influencing investment decisions and stock valuations in relevant sectors.
Analyst forecasts for Mdb Capital Holdings LLC (MDBH) are not currently available. The stock is trading at $3.85.
Analyst ratings for MDBH are not currently available. The stock is currently trading at $3.85. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for MDBH are not currently available. The stock is trading at $3.85.
The company identifies and invests in breakthrough innovations in sectors like biotechnology and life sciences. It provides financial support and expertise to early-stage companies, aiming to accelerate their commercialization and growth.
Price targets from Wall Street analysts for MDBH are not currently available. The stock is trading at $3.85.
Price targets from Wall Street analysts for MDBH are not currently available. The stock is trading at $3.85.
Analyst ratings for MDBH are not currently available. The stock is trading at $3.85.
Stock price projections, including those for Mdb Capital Holdings LLC, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.